Document and Entity Information
Document and Entity Information | Aug. 08, 2024 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Aug. 08, 2024 |
Entity Registrant Name | AMYLYX PHARMACEUTICALS, INC. |
Entity Central Index Key | 0001658551 |
Entity Incorporation State Country Code | DE |
Securities Act File Number | 001-41199 |
Entity Tax Identification Number | 46-4600503 |
Entity Address, Address Line One | 43 Thorndike, St., |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02141 |
City Area Code | (617) |
Local Phone Number | 682-0917 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.0001 par value per share |
Trading Symbol | AMLX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |